XML 64 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:        
Net income (loss) $ 795 $ 791 $ 1,572 $ 1,602
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (2,228) (1,642)
Provision for doubtful accounts 1,073 762 1,833 1,552
Depreciation and amortization 521 489 1,042 968
Income taxes     267 67
Gains on sales of facilities (2) (6) (3) (5)
Legal claim costs   10   22
Amortization of debt issuance costs     16 18
Share-based compensation     140 129
Other     45 37
Net cash provided by (used in) operating activities     2,684 2,748
Cash flows from investing activities:        
Purchase of property and equipment     (1,304) (1,172)
Acquisition of hospitals and health care entities     (295) (430)
Disposition of hospitals and health care entities     14 14
Change in investments     (11) 18
Other     5 15
Net cash used in investing activities     (1,591) (1,555)
Cash flows from financing activities:        
Issuance of long-term debt     1,502 3,000
Net change in revolving credit facilities     (1,160)  
Repayment of long-term debt     (95) (2,065)
Distributions to noncontrolling interests     (248) (205)
Payment of debt issuance costs     (25) (24)
Repurchases of common stock     (966) (1,858)
Other     (42) (91)
Net cash (used in) provided by financing activities     (1,034) (1,243)
Change in cash and cash equivalents     59 (50)
Cash and cash equivalents at beginning of period     646 741
Cash and cash equivalents at end of period 705 691 705 691
Eliminations [Member]        
Cash flows from operating activities:        
Net income (loss) (658) (641) (1,266) (1,270)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Equity in earnings of affiliates     1,266 1,270
HCA Healthcare, Inc. Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) 657 658 1,316 1,352
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     1 (23)
Income taxes     267 67
Equity in earnings of affiliates     (1,266) (1,270)
Other     39 37
Net cash provided by (used in) operating activities     357 163
Cash flows from financing activities:        
Repurchases of common stock     (966) (1,858)
Changes in intercompany balances with affiliates, net     671 1,799
Other     (62) (104)
Net cash (used in) provided by financing activities     (357) (163)
HCA Inc. Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) (476) (429) (939) (847)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (189) 66
Legal claim costs   10   22
Amortization of debt issuance costs     16 18
Net cash provided by (used in) operating activities     (1,112) (741)
Cash flows from financing activities:        
Issuance of long-term debt     1,500 3,000
Net change in revolving credit facilities     (1,160)  
Repayment of long-term debt     (42) (2,005)
Payment of debt issuance costs     (25) (24)
Changes in intercompany balances with affiliates, net     839 (230)
Net cash (used in) provided by financing activities     1,112 741
Subsidiary Guarantors [Member]        
Cash flows from operating activities:        
Net income (loss) 889 811 1,730 1,583
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (1,189) (1,140)
Provision for doubtful accounts 593 498 1,012 992
Depreciation and amortization 248 238 499 465
Gains on sales of facilities (1) (2) (1)  
Share-based compensation     140 129
Other       (2)
Net cash provided by (used in) operating activities     2,191 2,027
Cash flows from investing activities:        
Purchase of property and equipment     (578) (482)
Acquisition of hospitals and health care entities     (5) (148)
Disposition of hospitals and health care entities     10 9
Change in investments       3
Other     2 (1)
Net cash used in investing activities     (571) (619)
Cash flows from financing activities:        
Repayment of long-term debt     (33) (38)
Distributions to noncontrolling interests     (79) (29)
Changes in intercompany balances with affiliates, net     (1,463) (1,414)
Net cash (used in) provided by financing activities     (1,575) (1,481)
Change in cash and cash equivalents     45 (73)
Cash and cash equivalents at beginning of period     110 155
Cash and cash equivalents at end of period 155 82 155 82
Subsidiary Non-Guarantors [Member]        
Cash flows from operating activities:        
Net income (loss) 383 392 731 784
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (851) (545)
Provision for doubtful accounts 480 264 821 560
Depreciation and amortization 273 251 543 503
Gains on sales of facilities (1) (4) (2) (5)
Other     6 2
Net cash provided by (used in) operating activities     1,248 1,299
Cash flows from investing activities:        
Purchase of property and equipment     (726) (690)
Acquisition of hospitals and health care entities     (290) (282)
Disposition of hospitals and health care entities     4 5
Change in investments     (11) 15
Other     3 16
Net cash used in investing activities     (1,020) (936)
Cash flows from financing activities:        
Issuance of long-term debt     2  
Repayment of long-term debt     (20) (22)
Distributions to noncontrolling interests     (169) (176)
Changes in intercompany balances with affiliates, net     (47) (155)
Other     20 13
Net cash (used in) provided by financing activities     (214) (340)
Change in cash and cash equivalents     14 23
Cash and cash equivalents at beginning of period     536 586
Cash and cash equivalents at end of period $ 550 $ 609 $ 550 $ 609